Publication: QUINIDINE IN FALCIPARUM MALARIA
Issued Date
1981-11-14
Resource Type
ISSN
01406736
Other identifier(s)
2-s2.0-0019480346
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
The Lancet. Vol.318, No.8255 (1981), 1069-1071
Suggested Citation
Nicholas J. White, David A. Warrell, Danai Bunnag, Sornchai Looareesuwan, Tan Chongsuphajaisiddhi, Tranakchit Harinasuta QUINIDINE IN FALCIPARUM MALARIA. The Lancet. Vol.318, No.8255 (1981), 1069-1071. doi:10.1016/S0140-6736(81)91275-7 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/30224
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
QUINIDINE IN FALCIPARUM MALARIA
Other Contributor(s)
Abstract
Fourteen patients with falciparum malaria were successfully treated with oral quinidine. Twelve of these patients were followed for 35 days without recrudescence. In six patients the infection had already recrudesced after antimalarial treatment, which in two cases had included a full course of quinine. Quinidine caused no cardiotoxicity, although the electrocardiogram QTcinterval was prolonged by more than 25% in four patients. In-vitro cultures from nine of these patients and a further seven patients with falciparum malaria showed that the minimum inhibitory concentration was consistently lower for quinidine than for quinine. Quinidine is an effective antimalarial drug for Plasmodium falciparum infections and may be more potent than quinine. © 1981.